CD209 promoter single nucleotide polymorphism -336A/G and the risk of susceptibility to tuberculosis disease in the Moroccan population

International Journal of Human Genetics

Volumn 9, Issue 3-4, 2009, Pages 239-243

  Sadki, Khalid ^a   Lamsyah, Hoda ^a,c   Rueda, Blanca ^b   Lahlou, Ouafae ^a   El Aouad, Rajae ^a   Martin, Javier ^b  

^a INSTITUT NATIONAL D HYGIÈNE   (Morocco)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c FACULTÉ DES SCIENCES   (Morocco)

Author keywords

CD209; Genetic variation; Single nucleotide polymorphism; Tuberculosis

Indexed keywords

CD209 ANTIGEN; GENOMIC DNA;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNE RESPONSE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MOROCCO; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SPUTUM CULTURE; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULOSIS;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

EID: 76049085535     PISSN: 09723757     EISSN: None     Source Type: Journal    
DOI: 10.1080/09723757.2009.11886073     Document Type: Article

References (26)

1. Barreiro LB, Neyrolles O, Babb CL, Tailleux L, Quach H, et al 2006. Promoter Variation in the DC-SIGN-Encoding Gene CD209 Is Associated with Tuberculosis. PLoS Med, 3(2): e20.
2. Ben-Ali M, Barreiro LB, Chabbou A, Haltiti R, Braham E, et al 2007. Promoter and neck region length variation of DC-SIGN is not associated with susceptibility to tuberculosis in Tunisian patients. Hum Immunol, 68(11): 908-912.
3. Bergman MP, Engering A, Smits HH, Van Vliet SJ, Van Bodegraven AA, et al 2004. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med, 200: 979-990.
4. Boily-Larouche G, Zijenah L, Mbizvo M, Ward BJ, Roger M 2007. DC-SIGN and DC-SIGNR genetic diversity among different ethnic populations: Potential implications for pathogen recognition and disease susceptibility. Human Immunology, 68: 523-530.
5. Colmenares M, Puig-Kroger A, Pello OM, Corbi AL, Rivas L 2002. Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes. J Biol Chem, 277: 36766-36769.
6. Comstock GW 1978. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis, 117: 621-624.
7. Fortsch D, Mollinghoff M, Stenger S 2000. IL-10 converts human dendritic cells into macrophagelike cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J Immunol, 165: 978-987.
8. Geijtenbeek TB, Krooshoop DJ, Bleijs DA, Van Vliet SJ, Van Duijnhoven GC, et al 2000a. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol, 1: 353-357.
9. Geijtenbeek TB, Torensma R, Van Vliet SJ, Van Duijnhoven GC, Adema GJ, et al 2000b. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell, 100: 575-585.
10. Geijtenbeek TB, Van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CM, et al 2003. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med, 197: 7-17.
11. Gómez LM, Anaya JM, Sierra-Filardi E, Cadena J, Corbí A, et al 2006. Analysis of DC-SIGN (CD209) functional variants in patients with tuberculosis. Hum Immunol, 67(10): 808-811.
12. Halary F, Amara A, Lortat-Jacob H, Messerle M, Delaunay T, et al 2002. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity, 17: 653-664.
13. Henderson RA, Watkins SC, Flynn JL 1997. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol, 159: 635-643.
14. Hill AV 2006. Aspects of genetic susceptibility of human infectious diseases. Ann Rev Gent, 40: 469-486.
15. Jepson A, Fowler A, Banya W, Singh M, Bennett S, et al 2001. Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa. Infect Immun, 69: 3989-3994.
16. Olesen R, Wejse C, Velez DR, Bisseye C, Sodemann M, et al 2007. DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immun, 8(6): 456-467.
17. Pohlmann S, Soilleux EJ, Baribaud F, Leslie GJ, Morris LS, et al 2001. DCSIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans. Proc Natl Acad Sci U S A, 98: 2670-2675.
18. Sakuntabhai A, Turbpaiboon C, Casademont I, Chuansumrit A, Lowhnoo T, et al 2005. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet, 37: 507-513.
19. Selvaraj P, Alagarasu K, Swaminathan S, Harishankar M, Narendran G 2009. CD209 gene polymorphisms in South Indian HIV and HIV-TB patients. Infection, Genetics and Evolution, 9: 256-262
20. Serrano-Gomez D, Dominguez-Soto A, Ancochea J, Jimenez-Heffernan JA, Leal JA, et al 2004. Dendritic. cell-specific intercellular adhesion molecule 3-grabbing nonintegrin mediates binding and internalization of Aspergillus fumigatus conidia by dendritic cells and macrophages. J Immunol, 173(9): 5635-43
21. Tailleux L, Maeda N, Nigou J, Gicquel B, Neyrolles O 2003b. How is the phagocyte lectin keyboard played? Master class lesson by Mycobacterium tuberculosis. Trends Microbiol, 11(6): 259-263.
22. Tailleux L, Schwartz O, Herrmann JL, Pivert E, Jackson M, et al 2003a. DCSIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med, 197: 121-127.
23. Tailleux L, Pham-Thi N, Bergeron-Lafaurie A, Herrmann JL, Charles P, et al 2005. DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis. PLoS Med, 2: e38.
24. Vannberg FO, Chapman SJ, Khor CC, Tosh K, Floyd S, et al 2008. CD209 genetic polymorphism and tuberculosis disease. Plos One, 3(1): e1388.
25. Van Kooyk Y, Appelmelk B, Geijtenbeek TB 2003. A fatal attraction: Mycobacterium tuberculosis and HIV-1 target DC-SIGN to escape immune surveillance. Trends Mol Med, 9(4): 153-159
26. WHO Report 2007. Global Tuberculosis Control Surveillance, Planning, Financing. Geneva. WHO/HTM/TB/2007.376